In those with previously undiagnosed CeD (n = 43), higher antibody levels against GroEL were associated with an older age at sampling (67.2 years for GroEL-positive vs. 50.8 years for negative). This evidence concerns the gene HSPD1 and cranioectodermal dysplasia.